Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Health Catalyst, Inc. Director's Dealing 2020

Feb 21, 2020

33681_dirs_2020-02-20_c87c4a40-ed72-4317-b789-3af5c0cd417a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2020-02-14

Reporting Person: Bullock D Fraser (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-14 Common Stock J 609143.00 $0.00 Disposed 0.00 Indirect
2020-02-14 Common Stock J 29482.00 $0.00 Acquired 66271.00 Direct

Footnotes

F1: Represents a pro rata distribution for no consideration.

F2: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of these shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.